Survival Outcomes of Neoadjuvant mFOLFIRINOX for Resectable PDAC

Описание к видео Survival Outcomes of Neoadjuvant mFOLFIRINOX for Resectable PDAC

Michael Cecchini, MD, highlights his latest research evaluating the efficacy of neoadjuvant mFOLFIRINOX in improving survival and controlling micrometastasis in resectable pancreatic ductal adenocarcinoma.

0:00 Investigation Motivations
2:26 Study Design and Methodology
4:31 Correlation of Baseline ctDNA Levels With Patient Outcomes
6:30 OS and PFS
9:43 Further Research Needs
11:48 Final Thoughts

Комментарии

Информация по комментариям в разработке

Похожие видео